Certified by Founder
Lodge
Scindo
start up
United Kingdom
- London
- 23/09/2025
- Unknown
- $5,403,032
AI-powered enzyme discovery and design enables Scindo to create the next generation of biocatalysts for the future of sustainable manufacturing, transforming industrial chemistry through unprecedented control over selectivity - unlocking novel synthesis routes - while reducing energy, waste, and the reliance on fossil feedstocks. Our enzymes enable direct pathways between natural & renewable, or upcycled feedstocks and bioactive ingredients that are used in your daily lives, from cosmetics & personal care, to nutrients & foods.
- Industry Biotechnology Research
- Website https://www.scindo.bio/
- LinkedIn https://www.linkedin.com/company/scindo/
Zócalo Health | $15,000,000 | (Apr 24, 2026)
Rilian | $17,500,000 | (Apr 24, 2026)
BAND | $17,000,000 | (Apr 24, 2026)
Brev.io | $3,300,000 | (Apr 24, 2026)
Maxed | $850,000 | (Apr 24, 2026)
Omni | $120,000,000 | (Apr 24, 2026)
Astor (YC S25) | $5,000,000 | (Apr 24, 2026)
Almanac Health | $10,000,000 | (Apr 24, 2026)
Petual | $20,000,000 | (Apr 24, 2026)
Mosaic(US) | $18,000,000 | (Apr 23, 2026)
C-Infinity | $16,000,000 | (Apr 23, 2026)
Bubble Robotics | $5,000,000 | (Apr 23, 2026)